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Conclusion: Prevalence of cardiac involvement was 44%. Only
5% symptomatic. Mean CD4 lower in patients with cardiac disor-
der than those without. Lower CD4 count significantly associated
with pericardial effusion. 45% of the patients were receiving
ART and 55% were not. Noninvasive investigations like echocar-
diography helps in early diagnosis of asymptomatic cardiac dis-
orders. Cardiac disorders in HIV infected patients and only small
percentage of the patients with cardiac disorders are symptom-
atic.
Pacing & Electrophysiology
Effect of vacuum suction drainage system
placement on clinical outcomes during routine
permanent pacemaker implantation
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Azhar Zawed, R.K. Pandey, Naveen Bisht, Harish Mandal
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Background: Achieving adequate hemostasis in blind pacemaker
pocket is difficult. Pacemaker site hematoma with its attendant
complications is a frequent occurrence (17-25%) after permanent
pacemaker Implantation(PPI) especially in patients of ischemic
and valvular heart disease on anticoagulation and antiplatelet
therapy.
Methods: 84 patients requiring PPI were included in present study.
61 (72%) Patients were male, 23 (27%) patients were females. Clin-
ical presentation was syncope in 35 (41%) patients, complete heart
block in 46 (54%), Symptomatic sinus & Junctional Bradycardia in
10 cases (5%). 27 (32%) patients had coronary artery disease and
were on dual antiplatelets therapy with Ecosprin and Clopidogrel
/Prasugrel. Two ( 2.4%) patients of rheumatic heart diseasewere on
Acitrom. 89% patient received single chamber and 11% patient
received dual chamber pacemakers. Permanent Pacemaker was
implanted in routine manner in right infraclavicular fossa. As a
part of protocol MINI VAC closed wound suction drainage system
was placed into pacemaker pocket through separate dependent
portion of pacemaker site. Injection Targocid , Piptazwere used for
two days in therapeutic dosage as per hospital protocol. Patients
were discharged after 48 hours after removal of vacuum suction
drainage system and wound dressing. Patients were followed for
period of three months on regular basis.
Results: There was no incidence of pacemaker site hematoma,
local pain or tenderness, infection during hospital stay in all 84
patients. Neither these end points were observed during follow
period of three months.
Conclusion: Permanent pacemaker hematoma can be avoided
with routine use of vacuum suction drainage system placement
during permanent pacemaker implantation. There is no risk of
pacemaker pocket infection requiring repeated hospital admis-
sions and risk of explantation.
3D CARTO guided VT ablation in post MI patients
e A single centre experience
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Background: Radiofrequency ablation (RFA) for VT is an estab-
lished therapy in patients with ICD to reduce the number of
shocks. As many of our patients could not afford ICD, we offered
RFA as a primary therapy to these patients. We present our
experience of RF VT ablation in Indian population.
Methods: Patients who underwent RFA for VT ablation in our
centre from January 2008 toMay 2013 formed the study group.
Patients were categorized as Group I (with ICD) and Group II
(without ICD). Time-to-event analysis was performed. The pri-
mary end-points studied were VT recurrence and all-cause
mortality.
Results: Of 48 patients who underwent procedure,17 were in
Group I and 31 in Group II.
Median time-interval between ICD implantation and RFA in
Group I was 3yrs (Range: 1-12years). One hundred thirty nine
morphologically distinct ventricular tachycardias were induced in
the lab with an average of 2.6 VTs per patient. Hemodynamically
unstable or nonsustained VTs were 55% and hemodynamically
stable and sustained were 45%. Freedom from recurrence of VT
was observed in 77%with complete procedural success and 53% of
patients with partial success or procedure failure (p ¼ 0.22). The
freedom from recurrent VTs was 45% (N¼9) in Group I and 86%
(N¼3) in Group II (p¼0.0034) (Fig.1). Two patients had procedure
failure. All cause mortality was 4% (N¼2). There were no
arrhythmic deaths.
Conclusion: VT ablation is a safe procedure and can be considered
as a primary therapy in patients who cannot afford an ICD. In
patients with ICD, early preventive VT ablation at the time of ICD
implantation may be better than later curative therapy for
recurrent shocks.
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Background: There is no data on indications, clinical character-
istics of patients and type of cardiac implantable electrical devices
(CIED), including pacemakers, intracardiac defibrillators (ICD) and
cardiac resynchronization therapy (CRT) in India.
Aim: The CIED survey was conducted to document the type of
devices used, indications and capture demographic characteris-
tics, clinical status and co-morbidities of patients undergoing
these implants in India.
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Method: The CIED was a one-time survey initiated by the Indian
Society of Electrocardiology (ISE) and the Indian Heart Rhythm
Society (IHRS). The device survey forms were distributed to im-
planters across many centres in India. A total of 2117 device sur-
vey forms from 136 centres were collected from April 2012 to
March 2013.
Results: Pacemaker constituted almost 80% of the devices
implanted in India. The CIED were more frequently implanted in
males (64%) and in the sixth and seventh decade of life (51%).
Complete atrio-ventricular (AV) block was the indication of
pacemaker implantation in almost 80% of the patients. 54% pa-
tients received a single chamber pacemaker. In the ICD group
(10%), single chamber ICD was used in 65%; as a primary pro-
phylaxis indication in 52.5% and most often implanted in patients
with coronary artery disease (CAD). In theCRT group (10%), CRT-P
was used in 57% of these patients, 82% were in NYHA class III or
more and the left ventricular ejection fraction (LVEF) < 0.35 in 88%
of the patients.
Conclusion: Bradycardia pacemakers are the most common CIED
implanted in India with complete AV block being the indication in
vastmajority. In the ICD group, single chamber device was used in
two-thirds of the patients and primary prophylaxis use of ICD was
common. CRT-P devices were mainly used in patients with NYHA
III or more and LVEF < 0.35 or less.
Prognosis of drug-induced atrioventricular block
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Background: PM implantation is usually not considered in drug
related bradyarrhythmia (DRB). However, it is not clear whether
AV block is really caused by drugs or it merely exposes an un-
derlying AV conduction disease.
Methods: We prospectively studied 72 consecutive patients (66±
12 yrs, 42% women) with DRB (b-blockers, calcium channel
blockers and digitalis ) between February 2009 & march 2014.Pa-
tients with symptomatic type II 2 or 3 AV block ,2:1 AV block,
sinus bradycardia  40/min, AF with average V rate  40/min or
pause >5 secs were included in the study. Patients were excluded
if their AV block was attributed to acute MI, electrolyte imbal-
ances, digitalis toxicity and other antiarrhythmic drugs. Patients
were classified into 3 groups:1. DRB resolved after the discontin-
uation of culprit drug 2.DRB persisted after drug withdrawal or
recurred after initial resolution 3.DRB with undetermined corre-
lation: PM implanted and medication continued. The mean
follow-up duration was 16 ± 9 months.
Results: The level of AVB was infranodal in 51%, AV-nodal in 37 %
& undetermined in 12%. Drug discontinuation was followed by
resolution of AV block in 57% patients. However, 37 % patients
with resolution of AVB had recurrence in the absence of culprit
drug. Six patients had early recurrence during index hospitaliza-
tion. In 31% AVB persisted even after the discontinuation of
drugs.PM was implanted in all patients with persistent or recur-
rent AVB despite withdrawal of drug. Two patients with DRB-
undetermined relation underwent pacemaker implantation and
the medication continued. Thirty five patients with resolution of
AV block were discharged & followed up for an average of 16± 9
months. Two patients died and 9 patients had recurrence of AV
block in the absence of the culprit drugs.
Conclusions: Half of our patients (54%) with DRB had persistent
indication for PMevenafterwithdrawal ofAVblockers. PossiblyAV
blocking drugs merely exposed underlying AV conduction defect.
Ivabradine in AV nodal disease on dual chamber
pacemaker
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Background: The use of ivabradine as a rate reducing drug is well
documented. In normotensive individuals and those with
obstructive airway disease, the use of other rate reducing drugs
like beta blockers and calcium channel blockers have limitations.
Patients with AV nodal disease can have high atrial rates when
they have a dual chamber pacemaker implanted. The high atrial
rates are translated into high ventricular rates as the atrium is
tracked and ventricle is paced, often at the upper tracking rate
which is undesirable for the patient. The study focuses on the
novel use of ivabradine in reducing the atrial rate in patients with
AV nodal disease on dual chamber pacing.
Methods: During a 2 year period from July 2011 to July 2013, 85
patients with A-V block had dual chamber pacemaker implanted.
Within 3 months of implantation 12 patients presented with
palpitation. All the patients were on dual chamber rate respon-
sive pacemaker (DDDR). All of them had AV nodal disease
ecomplete AV dissociation in 8 and high degree AV block in 4
patients. On interrogation, all of them had high atrial rate epi-
sodes ranging from 90 to 116 beats per minute. Patients were put
on ivabradine 5mg twice daily in 8 patients and 7.5mg twice daily
in 4 patients.
Results: Out of the 12 patients, 9 were females and 3 weremales. 7
patients were diabetics. Obstructive airway disease in 5 and 3 of
them were hypertensive. The average incidence of ventricular
pacing was 96%. Atrial sensed ventricular pacing (AS-vp) was
noted on interrogation in11/12 patients (91.6%) Atrial paced ven-
tricular sensing (as-vp) in 1 patient .The patients could not
tolerate betablockers or calcium channel blockers. The average
ventricular pacing rate before ivabradine was 96/min(82-104- 96%
CI).The average dose of Ivabradine was 5mg twice a day in 8
patients(66%).In 4 patients the dosage requirement was 7.5mg
twice a day(33%).After administration of ivabradine ,the the
average pacing rate reduced significantly in all the patients. The
average rate of ventricular pacing was 80/min (76- 84- 98%CI) (p
<0.05) which was significantly less than the pre ivabradine rate.
Conclusion: The administration of ivabradine in patients on dual
chamber pacemaker with high atrial rates significantly reduces
the atrial rate and reduces the rate of atrial tracked ventricular
pacing.
Busting the myth of ventricular dysfunction
secondary to dyssynchrony in WPW syndromes
A.A. Cheriyan, P. Kamath, C. Rajiv
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Background: Ventricular dyssynchrony has been held responsible
for impaired LV function in pre-excitation syndromes especially
with left sided and posteroseptal accessory pathways (APs) due to
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